A Wish For Nonexistent Cheap Drugs Is Not Standing To Sue
By Nicholas LandauMay 25, 2018, 12:07 PM EDT
Law360 (May 25, 2018, 12:07 PM EDT) -- The recent releases of highly effective, and highly priced, drugs to treat chronic diseases has bred a spate of efforts by activists to disenfranchise drug developers of their patent rights. One recent chapter is instructive, as it demonstrates how choosing the wrong venue for your patent challenge can doom it before it even starts.
The Suit Against Genvoya and Related Drugs
The AIDS Healthcare Foundation is a global organization providing medicine and advocacy to HIV-infected patients in the U.S., Africa, Latin America/Caribbean, the Asia/Pacific Region and...